Patents by Inventor Ranran Du

Ranran Du has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240165015
    Abstract: Disclosed are a Lactobacillus rhamnosus strain having accession number CCTCC NO: M 2021185, a ferment lysate prepared thereby for regulating skin microecology, and a preparation method for the ferment lysate. The ferment lysate comprises the following components in mass percentages of same in the ferment lysate: 0.2-1% of proteins, 0.3-0.8% of polysaccharides, and 0.2-1% of amino acids. The ferment lysate obtained by using the above bacterial strain for fermentation can strongly inhibit the reproduction and growth of pathogenic bacteria, has a promotion effect on some of probiotics, has a strong inhibition effect on pathogenic hyphae of Candida albicans, can not only generate antimicrobial peptides during fermentation, but also increase the expression level of antimicrobial peptides in skin cells at the genetic level and the protein level, thereby improving skin immunity.
    Type: Application
    Filed: March 24, 2022
    Publication date: May 23, 2024
    Applicant: BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED
    Inventors: Zhen LU, Yujie WEI, Yuanjun SUN, Ranran DU, Yan ZHAO, Xueping GUO
  • Patent number: 11932881
    Abstract: A heparin skeleton synthase originates from Neisseria animaloris, with an amino acid sequence as shown in SEQ ID NO.2 and a nucleotide sequence of the coding gene as shown in SEQ ID NO.1. Its recombinant expression level is 6.8 times that of the existing heparin skeleton synthase KfiA from Escherichia coli K5, and total enzyme activity per fermentation liquor is 5.22 times that of the heparin skeleton synthase KfiA. The heparin skeleton synthase mutants obtained through site-directed mutagenesis of the sites No. 16, No. 25, No. 30, No. 111, No. 165, and No. 172 in the amino acid sequence of the said heparin skeleton synthase all have high expression levels.
    Type: Grant
    Filed: January 3, 2022
    Date of Patent: March 19, 2024
    Assignees: SHAN DONG UNIVERSITY, Bloomage Biotechnology Corporation Limited
    Inventors: Juzheng Sheng, Xueping Guo, Jianqun Deng, Fengshan Wang, Zhen Lu, Ranran Du, Liu Sun, Yuanjun Sun
  • Publication number: 20230407238
    Abstract: The present application provides a use of a hyaluronic acid or a salt thereof and/or trehalose in stabilizing ergothioneine, an additive for stabilizing ergothioneine, the additive containing the hyaluronic acid or the salt thereof and/or trehalose, and a composition, the composition containing ergothioneine, the hyaluronic acid or the salt thereof, and trehalose. Compared with other auxiliary materials, the hyaluronic acid or the salt thereof and trehalose provided by the present invention can obviously mitigate the damage of a high temperature to ergothioneine, thereby increasing the yield of an ergothioneine powder product. The composition obtained by the present invention has good antioxidant and anti-apoptotic effects.
    Type: Application
    Filed: November 9, 2021
    Publication date: December 21, 2023
    Applicants: BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED, BLOOMAGE BIOTECH (TIANJIN) CO., LTD.
    Inventors: Yujie WEI, Zhen LU, Qingping CHEN, Jie LI, Yuanjun SUN, Wenjuan XIE, Ranran DU, Wenyi GUO, Xueping GUO
  • Publication number: 20220267746
    Abstract: A heparin skeleton synthase originates from Neisseria animaloris, with an amino acid sequence as shown in SEQ ID NO.2 and a nucleotide sequence of the coding gene as shown in SEQ ID NO.1. Its recombinant expression level is 6.8 times that of the existing heparin skeleton synthase KfiA from Escherichia coli K5, and total enzyme activity per fermentation liquor is 5.22 times that of the heparin skeleton synthase KfiA. The heparin skeleton synthase mutants obtained through site-directed mutagenesis of the sites No. 16, No. 25, No. 30, No. 111, No. 165, and No. 172 in the amino acid sequence of the said heparin skeleton synthase all have high expression levels.
    Type: Application
    Filed: January 3, 2022
    Publication date: August 25, 2022
    Inventors: Juzheng Sheng, Xueping Guo, Jianqun Deng, Fengshan Wang, Zhen Lu, Ranran Du, Liu Sun, Yuanjun Sun
  • Patent number: 10242105
    Abstract: The present disclosure provides example methods and apparatuses for implementing comment ranking by a search engine. One or more terms describing a target object are extracted from a comment in connection with the target object. One or more useful attributes included in the comment are obtained according to the terms describing the target object. An scoring index the comment is determined according to a number of the useful attributes. The comment is scored according to the index. The comment is ranked according to the score. The present techniques enable a user to quickly and efficiently view helpful comments and help the user make an informed decision.
    Type: Grant
    Filed: June 18, 2014
    Date of Patent: March 26, 2019
    Assignee: Alibaba Group Holding Limited
    Inventors: Ranran Du, Yongbin Lin
  • Publication number: 20140379682
    Abstract: The present disclosure provides example methods and apparatuses for implementing comment ranking by a search engine. One or more terms describing a target object are extracted from a comment in connection with the target object. One or more useful attributes included in the comment are obtained according to the terms describing the target object. An scoring index the comment is determined according to a number of the useful attributes. The comment is scored according to the index. The comment is ranked according to the score. The present techniques enable a user to quickly and efficiently view helpful comments and help the user make an informed decision.
    Type: Application
    Filed: June 18, 2014
    Publication date: December 25, 2014
    Inventors: Ranran Du, Yongbin Lin